JORDEN DAVID EMERSON - Insider Non-Derivative Transactions at Nuo Therapeutics, Inc. (AURX) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 28, 2025, JORDEN DAVID EMERSON's relationship to Nuo Therapeutics, Inc. (AURX) is Director,Officer (CEO/CFO), and currently has 1,946,755 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AURX insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

JORDEN DAVID EMERSON - Insider Non-Derivative Transactions of AURX Common Stock

JORDEN DAVID EMERSON - Insider Non-Derivative Transactions at AURX

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 29, 2025	Sell -- (Common Stock)	200000	1.5	1946755
Aug 2, 2025	M -- (Common Stock)	100000	0.4	2075358
Aug 2, 2025	F -- (Common Stock)	21313	1.74	2146755
Aug 2, 2025	M -- (Common Stock)	92710	0.4	2168068